115 related articles for article (PubMed ID: 10845947)
1. Diabetes care needs evidence based interventions to reduce risk of vascular disease.
Byrne CD; Wild SH
BMJ; 2000 Jun; 320(7249):1554-5. PubMed ID: 10845947
[No Abstract] [Full Text] [Related]
2. Incidence and predictors of silent myocardial infarction in type 2 diabetes and the effect of fenofibrate: an analysis from the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Burgess DC; Hunt D; Li L; Zannino D; Williamson E; Davis TM; Laakso M; Kesäniemi YA; Zhang J; Sy RW; Lehto S; Mann S; Keech AC
Eur Heart J; 2010 Jan; 31(1):92-9. PubMed ID: 19797259
[TBL] [Abstract][Full Text] [Related]
3. Need for large scale randomised evidence about lowering LDL cholesterol in people with diabetes mellitus: MRC/BHF heart protection study and other major trials.
Armitage J; Collins R
Heart; 2000 Oct; 84(4):357-60. PubMed ID: 10995396
[No Abstract] [Full Text] [Related]
4. [Myocardial infarction in patients with diabetes mellitus type 2].
Ochotny R; Piszczek I; Błaszyk K; Poprawski K
Kardiol Pol; 1988; 31(9):563-8. PubMed ID: 3244232
[No Abstract] [Full Text] [Related]
5. Should you put all diabetic patients on statins?
Leiter LA
J Fam Pract; 2007 Apr; 56(4):294-300. PubMed ID: 17403328
[No Abstract] [Full Text] [Related]
6. Therapy and clinical trials: fibrate therapy in type 2 diabetes - where are we now?
Peter R; Reilly E; Anthony S
Curr Opin Lipidol; 2010 Dec; 21(6):554-5. PubMed ID: 21206346
[No Abstract] [Full Text] [Related]
7. [Critical evaluation of a "therapeutic study"].
Praxis (Bern 1994); 1997 Oct; 86(41):1603-7. PubMed ID: 9417581
[No Abstract] [Full Text] [Related]
8. Effect of gender on prognosis in patients with myocardial infarction and type 2 diabetes.
Venskutonyte L; Malmberg K; Norhammar A; Wedel H; Rydén L
J Intern Med; 2010 Jul; 268(1):75-82. PubMed ID: 20210844
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic abnormalities in diabetes mellitus: association between T-wave changes and nephropathy.
Faierman D; Bloomgarden ZT; Nechemias C; Brown WV
Mt Sinai J Med; 1986 Apr; 53(4):254-9. PubMed ID: 3487720
[No Abstract] [Full Text] [Related]
10. [Dangerous duo: hypertension and pre-diabetes--the underestimated risk].
MMW Fortschr Med; 2003 Jan; 145(3-4):54-5. PubMed ID: 12619235
[No Abstract] [Full Text] [Related]
11. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
Mazzone T
Am J Med; 2007 Sep; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trials remain fundamental to clinical decision making in Type II diabetes mellitus: a comment to the debate on randomized controlled trials (For debate).
Richter B; Berger M
Diabetologia; 2000 Apr; 43(4):528-32. PubMed ID: 10819251
[No Abstract] [Full Text] [Related]
13. Concurrent blood pressure, glycemic and lipid control for the prevention of vascular complications of type II diabetes mellitus: a long overdue objective?
Athyros VG; Mitsiou EK; Tziomalos K; Karagiannis A; Mikhailidis DP
Curr Vasc Pharmacol; 2010 Jan; 8(1):1-4. PubMed ID: 20394107
[No Abstract] [Full Text] [Related]
14. [Prevention of cardiovascular disease in type 2 diabetic patients].
Yokota C
Nihon Rinsho; 2003 Jul; 61(7):1161-6. PubMed ID: 12877078
[TBL] [Abstract][Full Text] [Related]
15. Teaching and motivating patients to control their risk factors retards progression of cardiovascular as well as microvascular sequelae of Type 2 diabetes mellitus- a randomized prospective 8 years follow-up study.
Rachmani R; Slavachevski I; Berla M; Frommer-Shapira R; Ravid M
Diabet Med; 2005 Apr; 22(4):410-4. PubMed ID: 15787665
[TBL] [Abstract][Full Text] [Related]
16. [The effect of metformin on late diabetic complications and cardiovascular events in obese patients with type 2 diabetes].
Christiansen AL; Madsbad S
Ugeskr Laeger; 2002 Apr; 164(15):2022-4. PubMed ID: 11984999
[TBL] [Abstract][Full Text] [Related]
17. No evidence for a reduction of myocardial infarctions by acarbose.
van de Laar FA; Lucassen PL
Eur Heart J; 2004 Jul; 25(13):1179; author reply 1179-80. PubMed ID: 15231377
[No Abstract] [Full Text] [Related]
18. [High blood glucose in diabetics a risk factor in acute myocardial infarction. Intensive insulin therapy--an interesting but not functioning idea].
Dellborg M; Svensson AM
Lakartidningen; 2006 Sep 13-19; 103(37):2624-5. PubMed ID: 17022181
[No Abstract] [Full Text] [Related]
19. Efficacy of lipid lowering drug treatment for diabetic and non-diabetic patients: meta-analysis of randomised controlled trials.
Costa J; Borges M; David C; Vaz Carneiro A
BMJ; 2006 May; 332(7550):1115-24. PubMed ID: 16585050
[TBL] [Abstract][Full Text] [Related]
20. Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia.
Hayes AJ; Leal J; Kelman CW; Clarke PM
Diabet Med; 2011 Apr; 28(4):428-35. PubMed ID: 21392064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
